SEC Tracker
Get the app
PSNL · XBRL financial data

Personalis financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PSNL's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers18,24719,675*19,52522,58025,70916,800*20,60517,20314,49517,345*15,47222,357
Cost of revenue14,76614,470*14,03214,54316,96412,250*13,39812,44712,58115,445*15,19117,614
Research and development16,73813,613*12,77112,95711,68311,494*12,64012,38112,17113,072*14,53916,336
Selling, general and administrative11,97111,524*11,60211,97311,44411,168*12,26314,17913,03414,094*17,90321,998
Operating income (loss)(30,793)(23,972)*(18,880)(16,893)(14,382)(18,112)*(17,696)(21,804)(23,291)(25,266)*(32,161)(33,591)
Interest income1,7061,477*1,3591,1361,3841,631*2,0271,8781,6801,570*2,1721,966
Interest expense159*997(1)*28486465*4737
Other income (expense)32(4,075)*4,5692,968(26,081)59*(46)(80)26(42)*20(16)
Income tax expense (benefit)285*7434*7239*165
Net income (loss)(29,098)(26,584)*(12,968)(12,802)(39,089)(16,425)*(15,750)(20,056)(21,652)(23,812)*(30,032)(31,683)
Earnings per share, basic USD per share(0.60)(0.54)*(0.26)(0.24)(0.64)(0.23)*(0.18)(0.23)(0.24)(0.26)*(0.29)(0.30)
Earnings per share, diluted USD per share(0.60)(0.54)*(0.26)(0.24)(0.64)(0.23)*(0.18)(0.23)(0.24)(0.26)*(0.29)(0.30)
Weighted average shares, basic thousands of shares48,69449,560*50,67952,39561,05172,712*87,46488,51788,69992,235*104,192105,425
Weighted average shares, diluted thousands of shares48,69449,560*50,67952,39561,05172,712*87,46488,51788,69992,235*104,192105,425

Balance sheet

CSV

Fiscal quarters (PSNL's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents72,19256,98443,98147,74775,80091,41571,00153,37449,973124,24573,59493,968
Short-term investments48,47157,19551,43839,22567,85193,594114,687119,858100,542115,708159,624118,690
Accounts receivable13,66617,73011,34512,92113,4748,14010,9739,95214,37616,20313,02215,102
Prepaid and other current assets5,6614,3614,9084,0464,6633,9274,8384,7244,8555,6515,0287,654
Total current assets148,215146,744120,439113,103170,277203,015206,422193,343174,402267,951258,198245,052
Property and equipment, net56,75157,36654,52952,66250,23148,27447,98645,81247,00344,81548,43848,567
Right-of-use asset18,16717,85217,51517,16616,81616,45316,05515,65415,24915,11814,95714,860
Total assets226,636225,099195,276185,502239,887270,268273,308258,680242,839334,164325,395312,135
Accounts payable8,96314,9209,1799,93612,4506,3977,9149,92611,14712,98912,67616,005
Accrued liabilities1,9758581,1262,4061,471———————
Total current liabilities32,47847,23431,37334,13336,41331,12629,89231,72336,15639,63039,04546,385
Lease liability, non-current39,16638,32137,43436,52435,60134,88234,11233,39032,65831,86631,02330,167
Total liabilities75,43095,65874,58273,23073,12667,31165,96367,85171,42472,97970,63076,974
Accumulated deficit(442,122)(468,706)(481,674)(494,476)(533,565)(549,990)(565,740)(585,796)(607,448)(631,260)(661,292)(692,975)
Total stockholders' equity151,206129,441120,694112,272166,761202,957207,345190,829171,415261,185254,765235,161
Total liabilities and equity226,636225,099195,276185,502239,887270,268273,308258,680242,839334,164325,395312,135
Common shares outstanding (cover page) thousands of shares49,03150,50451,93953,07570,64888,26388,32588,67788,804104,632104,721106,800

Cash flows

CSV

Fiscal quarters (PSNL's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(29,098)(26,584)*(12,968)(12,802)(39,089)(16,425)*(15,750)(20,056)(21,652)(23,812)*(30,032)(31,683)
Stock-based compensation3,482*3,389*2,6872,653*2,677*2,669*2,2192,830*2,082*2,298*2,5533,981*
Depreciation and amortization2,8002,907*2,8372,8002,8002,543*2,5872,5002,466*2,462*2,3712,414*
Net cash from operating activities(16,681)*(13,418)*(20,413)(10,743)*(6,198)*(7,796)*(17,961)(12,935)*(21,804)*(22,246)*(22,478)(25,770)*
Purchases of property and equipment868*3,524*1046*247*1,246*2,511290*1,626*77*3,1923,782*
Net cash from investing activities(8,605)*(11,638)*6,30112,993*(28,180)*(26,183)*(22,542)(4,371)*18,724*(14,379)*(46,012)38,163*
Proceeds from issuing common stock725*915*1,4371,405*27,237*0*17,7820*0*109,015*20,9524,551*
Net cash from financing activities290*9,816*1,1291,516*62,426*49,601*20,087(327)*(317)*110,895*17,8307,988*
Net change in cash(25,003)*(15,208)*(13,003)3,766*28,053*15,615*(20,414)(17,627)*(3,401)*74,272*(50,651)20,374*

Compare with peers

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Personalis98,27125,596(27,072)*108.4M6.7 quarters 10-QSep 30, 2026
Castle Biosciences62,116103,54615,201*30.5M— 10-QJun 30, 2026
Celcuity182,049not reported(55,426)*48.9M13.6 quarters 10-QJun 30, 2026
Fortrea Holdings220,600691,50060,800*96.5M— 10-QSep 30, 2026
CareDx250,480139,36212,718*52.5M— 10-QSep 30, 2026
Fulgent Genetics26,30585,389(23,758)*27.5M10.8 quarters 10-QJun 30, 2026
Veracyte299,521150,32145,826*80.4M— 10-QJun 30, 2026
GRAIL55,64544,687(80,730)*44.7M0.7 quarters 10-QJun 30, 2026
Exagen24,58819,9413,988*24.2M— 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.